Mark S. Lesney Archives - Page 2 of 4

News
SARS epidemiology provides clues to potential treatment for COVID-19
March 5, 2020
A clinically proven effective protease inhibitor blocks SARS-CoV-2 virus entrance sites.
News
ID consult for Candida bloodstream infections can reduce mortality risk
January 12, 2020
More patients survived Candida bloodstream infections when they had ID consultations.
Article
FDA approves cefiderocol for multidrug-resistant, complicated urinary tract infections
November 15, 2019
The approval is for patients with limited or no alternative treatment options and includes a warning of Fetroja’s higher all-cause mortality rate.
News
CDC releases update of 2013 Antibiotic Resistance Threats Report
November 14, 2019
The report includes the hopeful news that there were 42 new antibiotics in development as of June 2019.
News
CDC: Don’t vape, especially THC
October 22, 2019
The cause of e-cigarette, or vaping, product use–associated lung injury (EVALI) is unknown, but a Utah study found a link to THC-containing products.
News
Guidelines updated for treating community-acquired pneumonia
October 18, 2019
The new guidelines update those from 2007 and include recommended changes in antibiotic treatment and the elimination of the category known as health care–acquired pneumonia.
Opinion
IDWeek examined hot topics in the clinical treatment of infectious diseases
October 6, 2019
WASHINGTON – Identifying diseases using cell-free microbial DNA from plasma and next-generation DNA sequencing are some of the hot topics in ID diagnosis and treatment.
News
Hospital-acquired C. diff. tied to four ‘high-risk’ antibiotic classes
September 16, 2019
High-risk antibiotics included second-, third-, and fourth-generation cephalosporins, fluoroquinolones, carbapenems, and lincosamides.
News
FDA approves drug combo to treat highly resistant TB
August 14, 2019
The combination of pretomanid tablets with bedaquiline and linezolid primarily was approved for a limited population infected with drug resistant TB.
News
Patients with COPD at heightened risk for community-acquired pneumonia requiring hospitalization
July 11, 2019
COPD patients were about 18 times more likely to develop community-acquired pneumonia requiring hospitalization.